The Division of Signal Transduction Therapy or DSTT is an organization managed by the University of Dundee,[1] the Medical Research Council, and the pharmaceutical companies AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Merck Serono, Janssen Pharmaceutica, and Pfizer.
[2] It is made up from fifteen research teams based at the University of Dundee and along with support personnel totals nearly 200 members of staff.
The amount of funding and staff make DSTT the largest collaboration between the for-profit pharmaceutical industry and a university in the United Kingdom.
The DSTT itself produces protein and lipid kinases, phosphatases and ubiquitin reagents for member companies to use in research and as targets for high-throughput screening.
The University of Dundee received a Queen's Anniversary Prize in recognition of the DSTT being a model for research sharing between academic and commercial sectors.